Global AI-Powered mRNA Drug Discovery & Development Market Size is predicted to grow with a 24.7% CAGR during the forecast period for 2025-2034.
AI-powered mRNA drug discovery & development market refers to the sector encompassing integrated systems that leverage artificial intelligence (AI) to accelerate and optimize the design, development, production, and commercialization of mRNA-based therapeutics and vaccines. This market includes companies providing AI-mRNA software and platforms, those developing AI-optimized mRNA drugs and vaccines, and those offering AI-powered contract research organization (CRO) services for mRNA.
These entities combine advanced computational techniques, machine learning, and data analytics to streamline processes across the mRNA value chain, from sequence design to clinical trials and manufacturing, enhancing efficiency, reducing costs, and improving therapeutic outcomes. The mRNA sector is a fast-growing sector in biotech and pharma. AI is revolutionising the mRNA field by speeding up the development of mRNA therapeutics and vaccines. Machine learning and data analytics help optimise mRNA sequences for greater stability, effectiveness, and scalability. AI helps clinical trials and manufacturing by analyzing large datasets to find the best mRNA targets and predict patient responses, advancing personalized medicine.
Rising demand for innovative therapies and vaccines, advancements in mRNA technology, high R&D costs and need for efficiency, growth of personalized medicine, high R&D costs and need for efficiency, growth of personalized medicine and regulatory agencies like the FDA and ema are increasingly approving mRNA-based products, boosted by the rapid authorization of COVID-19 vaccines. Additionally, streamlined regulatory pathways encourage investment in mRNA development
Nevertheless, challenges like expensive production and cumbersome regulatory environments remain formidable hurdles that may hinder approval and commercialization of AI-based mRNA therapies.
Some of the Key Players in AI-Powered mRNA Drug Discovery & Development Market are:
The AI-Powered mRNA Drug Discovery & Development market is segmented by application, therapeutic area, technology type, and end-user. By application market is segmented into prophylactic vaccines, therapeutic vaccines, protein replacement therapies, gene editing support. By therapeutic area, the market is segmented into infectious diseases, oncology, rare genetic diseases, cardiovascular & metabolic disorders. By Technology Type market is segmented into sequence optimization, delivery systems, predictive modeling, and manufacturing optimization. By end-user the market is segmented into hospitals & clinics, research organizations, pharmaceutical companies.
The infectious diseases segment accounts for the major growth driver of the AI-powered mRNA drug discovery & development market, driven by the success of mRNA COVID-19 vaccines from Pfizer-BioNTech and Moderna, which were shown to have high efficacy, have been rapidly developed, and capable of being modified to viral variants. mRNA vaccines have several advantages over conventional vaccines, including rapid development, scalable production, and enhanced safety, all further boosted by AI with optimized sequence design and immune response prediction. Regulatory clearances, including FDA emergency use authorizations, and greater investments in pandemic preparedness and immunization initiatives have strengthened public confidence and fueled market growth in this segment.
Sequence optimization is becoming a prime technology in the AI-powered mRNA drug discovery & development market, improving mRNA stability, translation efficiency, and therapeutic effect. AI tools such as LinearDesign and RiboCode redesign mRNA sequences to drastically increase protein yield—up to 128-fold in certain instances—by optimizing secondary structure and codon usage. AI tools efficiently search the vast mRNA design space to identify optimal sequences, using advanced models that incorporate cellular context and experimental data for precise, tailored mRNA designs, advancing the field beyond traditional methods.
North America is estimated to dominate the AI-powered mRNA drug discovery & development market, backed by robust research infrastructure, high government funding (e.g., NIH, Department of Defense), and the presence of industry leaders such as Moderna and Pfizer-BioNTech. The region enjoys a well-developed regulatory environment with clear guidelines and emergency use authorizations, quick take-up of AI and machine learning technologies, and influential public-private initiatives such as Operation Warp Speed, all of which have fast-tracked mRNA research, development, and commercialization.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 24.7 % from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By, Application, Therapeutic Area, Technology Type, End-User and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Moderna, BioNTech, CureVac, Nutcracker Therapeutics, Ethris, Baidu (LinearDesign), IBM, DeepMind (Alphabet), Anima Biotech, Translate Bio (Sanofi) |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Powered mRNA Drug Discovery & Development Market Snapshot
Chapter 4. Global AI-Powered mRNA Drug Discovery & Development Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on AI-Powered mRNA Drug Discovery & Development Market Industry Trends
4.10. Global AI-Powered mRNA Drug Discovery & Development Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI-Powered mRNA Drug Discovery & Development Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
5.2.1. Prophylactic Vaccines
5.2.2. Therapeutic Vaccines
5.2.3. Protein Replacement Therapies
5.2.4. Gene Editing Support
Chapter 6. AI-Powered mRNA Drug Discovery & Development Market Segmentation 2: By Therapeutic Area, Estimates & Trend Analysis
6.1. Market Share by Therapeutic Area, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Area:
6.2.1. Infectious Diseases
6.2.2. Oncology
6.2.3. Rare Genetic Diseases
6.2.4. Cardiovascular & Metabolic Disorders
Chapter 7. AI-Powered mRNA Drug Discovery & Development Market Segmentation 3: By Technology Type, Estimates & Trend Analysis
7.1. Market Share by Technology Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:
7.2.1. Sequence Optimization
7.2.2. Delivery Systems
7.2.3. Predictive Modeling
7.2.4. Manufacturing Optimization
Chapter 8. AI-Powered mRNA Drug Discovery & Development Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
8.2.1. Hospitals & Clinics
8.2.2. Research Organizations
8.2.3. Pharmaceutical Companies
Chapter 9. AI-Powered mRNA Drug Discovery & Development Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global AI-Powered mRNA Drug Discovery & Development Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.3. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.2.4. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.2.5. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3. Europe
9.3.1. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.3. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.3.4. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.3.5. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.3. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.4.4. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.4.5. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5. Latin America
9.5.1. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.3. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.5.4. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.5.5. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.3. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.6.4. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.6.5. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Moderna
10.2.1.1. Business Overview
10.2.1.2. Key Application/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. CureVac
10.2.3. Nutcracker Therapeutics
10.2.4. Ethris
10.2.5. Baidu (LinearDesign)
10.2.6. IBM
10.2.7. DeepMind (Alphabet)
10.2.8. Anima Biotech
10.2.9. Translate Bio (Sanofi)
Segmentation of AI-Powered mRNA Drug Discovery & Development Market -
AI-Powered mRNA Drug Discovery & Development Market by Application -
AI-Powered mRNA Drug Discovery & Development Market by Therapeutic Area-
AI-Powered mRNA Drug Discovery & Development Market by Technology Type -
AI-Powered mRNA Drug Discovery & Development Market by End-User -
AI-Powered mRNA Drug Discovery & Development Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
